Related Experiment Video
Updated: May 17, 2026
08:48
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
Published on: January 29, 2016
Understanding hope in patients with Multiple Sclerosis.
Andy Soundy1, James Benson, Helen Dawes
1School of Health and Population Sciences, University of Birmingham, 52 Pritchatts Road, Edgbaston, Birmingham, B15 2TT, UK. A.A.Soundy@bham.ac.uk
Physiotherapy
|November 6, 2012
Summary
Patients with Multiple Sclerosis express hope through defiance, acceptance of diagnosis, and acceptance of deterioration. Understanding these themes is crucial for therapists in rehabilitation settings.
Area of Science:
- Neurology
- Psychology
- Rehabilitation Medicine
Background:
- Multiple Sclerosis (MS) presents unique challenges for patients navigating chronic illness.
- Rehabilitation settings offer a critical environment for understanding patient experiences.
Purpose of the Study:
- To explore how patients with Multiple Sclerosis (MS) experience and express hope during rehabilitation.
- To provide insights for therapists to better support MS patients in clinical settings.
Main Methods:
- Semi-structured interviews were conducted with eleven MS patients undergoing a 12-week rehabilitation program.
- Interviews occurred mid-program and post-program at a rehabilitation center and an MS society meeting.
- Categorical content analysis was used to analyze interview data.
Main Results:
- Three primary themes emerged regarding the paradox of chronic illness: defiance, acceptance of diagnosis/prognosis, and acceptance of deterioration.
- These themes illuminate the diverse ways MS patients express hope.
- Patient narratives reveal distinct coping mechanisms and aspirations.
Conclusions:
- Understanding the paradox of chronic illness is vital for comprehending hope in MS patients.
- Listening to patient narratives during rehabilitation is essential for effective therapeutic interventions.
- This research underscores the importance of patient-centered care in MS rehabilitation.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...